Ruping Zhao
Overview
Explore the profile of Ruping Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng H, E X, Lv M, Zeng S, Feng Y, Shen W, et al.
Radiat Oncol
. 2025 Jan;
20(1):12.
PMID: 39844209
Purpose: Conventional radiotherapy (CRT) has limited local control and poses a high risk of severe toxicity in large lung tumors. This study aimed to develop an integrated treatment plan that...
2.
Zeng H, Chen Q, E X, Feng Y, Lv M, Zeng S, et al.
J Appl Clin Med Phys
. 2024 Nov;
26(2):e14582.
PMID: 39611881
Background: Lung cancer poses a significant global health challenge. Adaptive radiotherapy (ART) addresses uncertainties due to lung tumor dynamics. We aimed to investigate a comprehensively and systematically validated offline ART...
3.
Rudat V, Zhao R, Wang B, Zhang L, Shi Y
Sci Rep
. 2024 Nov;
14(1):27814.
PMID: 39537683
The goal of the study was to assess the impact of deep inspiration breath hold technique (DIBH), surface-guided radiotherapy (SGRT), and daily kilovoltage cone-beam computed tomography (kV-CBCT) on the dose...
4.
Lv M, Feng Y, Zeng S, Zhang Y, Shen W, Guan W, et al.
Radiat Oncol
. 2024 Nov;
19(1):157.
PMID: 39529129
Background: Recent research has demonstrated that the use of artificial intelligence (AI) in radiotherapy (RT) has significantly streamlined the process for physicians to treat patients with tumors; however, bibliometric studies...
5.
Ma S, Xie F, Wen X, Adzavon Y, Zhao R, Zhao J, et al.
Pharmacol Res
. 2024 Nov;
210:107490.
PMID: 39510148
The emergence of sorafenib resistance has become a predominant impediment and formidable dilemma in the therapeutic approach for hepatocellular carcinoma (HCC). Although the approval of next-generation drugs as alternatives to...
6.
Lv M, Feng Y, Zeng S, Zhang Y, Shen W, Guan W, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Aug;
398(2):1583-1595.
PMID: 39120721
Autophagy was considered to induce resistance in chemotherapy, which was significantly associated with proliferation of cancer; however, few bibliometric studies on the relation between autophagy and chemotherapy in lung cancer...
7.
Xia F, Wang Y, Wang H, Shen L, Xiang Z, Zhao Y, et al.
J Clin Oncol
. 2024 Jul;
42(28):3308-3318.
PMID: 38950321
PURPOSETo assess whether the integration of PD-1 inhibitor with total neoadjuvant therapy (iTNT) can lead to an improvement in complete responses (CRs) and favors a watch-and-wait (WW) strategy in patients...
8.
Lv M, Feng Y, Zeng S, Zhang Y, Shen W, Guan W, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Jun;
397(12):9789-9809.
PMID: 38918234
Radiation pneumonia is a common adverse reaction during radiotherapy in lung cancer patients, which negatively impacts the quality of life and survival of patients. Recent studies have shown that compound...
9.
Rudat V, Shi Y, Zhao R, Yu W
J Appl Clin Med Phys
. 2024 Jan;
25(6):e14271.
PMID: 38273673
Purpose: The use of volumetric modulated arc therapy (VMAT), simultaneous integrated boost (SIB), and hypofractionated regimen requires adequate patient setup accuracy to achieve an optimal outcome. The purpose of this...
10.
Rudat V, Shi Y, Zhao R, Xu S, Yu W
Sci Rep
. 2023 Oct;
13(1):17018.
PMID: 37813917
The goal of the study was to evaluate the inter- and intrafractional patient setup accuracy of target volumes located in the head, thoracic, abdominal, and pelvic regions when using SGRT,...